| Printer Friendly Click to print this page| Add to Favorites Click to add to favorites| Font Size
:
HOME FAQ CONTACT US LINKS SITEMAP MEDCOM ARMY.MIL AKO

About USAMMDA

Litter

USAMMDA is the Department of Defense's (DoD) advanced development activity for products designed to protect and preserve the lives of Warfighters. USAMMDA develops new drugs, vaccines and medical support equipment that enhance readiness, ensures the provision of the highest quality medical care to the DoD and maximizes survival of medical casualties on the battlefield.

USAMMDA project managers guide the advanced development of medical products for the U.S. Army Medical Department, other U.S. Services, the Joint Staff, the Office of the Secretary of Defense and U.S. Special Forces community. The process takes promising technology from DoD and academia to U.S. Forces, from the testing required for FDA approval or licensing to fielding of the finished product.

USAMMDA Accomplishes its mission by exercising three core capabilities:

  • Program management for USAMRMC advanced development projects
  • Regulated activities of all protocols conducted using Investigational New Drugs (IND) applications or Investigational Device Exemptions
  • Coordinate The Surgeon General's Executive Agent management of Force Health Protection's INDs

 

Topical Paromomycin Clinical Trial
Vehicle Extraction Strap CCFP Application
MRAP Ambulance SMRC IND/EUA team exercise
Last Modified Date: 22-Sep-2015